570 556 captures · dernière capture : 3 mai 2026
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
386 223 captures · dernière capture : 14 avr. 2026
243 880 captures · dernière capture : 28 avr. 2026
How to comply with procedures under Canada's Access to Medicines Regime Instructions for complying with the Requirements of Canada's Access to Medicines Regime specify how to notify the World Trade Organization or the Government of Canada, and how to request the addition of a…
Notification requirements for importing countries under Canada's Access to Medicines Regime Eligible countries are required to notify the World Trade Organization (WTO) or the Government of Canada of their plans to use Canada's Access to Medicines Regime . Each reporting…
Importing countries under Canada's Access to Medicines Regime An eligible country wanting to import a generic version of a patented drug or medical device under Canada's Access to Medicines Regime must meet the following requirements: Identify a drug or medical device that is on…
WTO-member countries and non-WTO member countries eligible to import under Canada's Access to Medicines Regime Patent Act WTO-Member Countries and Non-WTO Member Countries Eligible to Import Under the Regime An Act to amend the Patent Act and the Food and Drugs Act (Paragraph…
WTO-member countries eligible to import under Canada's Access to Medicines Regime Patent Act WTO-Member Countries Eligible to Import Under the Regime An Act to amend the Patent Act and the Food and Drugs Act (Paragraph 21.03(1)(c)) Albania Egypt Nicaragua Antigua and Barbuda El…
Least-developed countries eligible to import under Canada's Access to Medicines Regime Patent Act Least-Developed Countries Eligible to Import Under the Regime An Act to amend the Patent Act and the Food and Drugs Act (Paragraph 21.03(1)(b)) Afghanistan Gambia Rwanda Angola…
Countries eligible for Canada's Access to Medicines Regime The list of countries eligible to participate in Canada's Access to Medicines Regime includes countries that are members of the World Trade Organization (WTO). However, 23 member countries, including Canada, have…
Review process under Canada's Access to Medicines Regime Countries can be assured that products purchased under Canada's Access to Medicines Regime meet the same health and safety standards as products sold in Canada. Manufacturers are required to submit scientific evidence of a…
Capacity to manufacture under Canada's Access to Medicines Regime Canada's Access to Medicines Regime is designed to help least-developed and developing countries that have little or no manufacturing capacity in the pharmaceutical sector. To participate in the Regime, an eligible…
Features of Canada's Access to Medicines Regime The World Trade Organization (WTO) decision of August 2003 established the basic framework for a compulsory licence for export regime. Within that framework, each WTO member decides for itself how it will implement the decision…
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
